Baudax Bio, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Debt - Additional Information (Details)

Debt - Additional Information (Details) - USD ($) $ / shares in Units, $ in Thousands									1 Months Ended			2 Months Ended			3 Months Ended					9 Months Ended		12 Months Ended
	May 31, 2023	Apr. 03, 2023	Mar. 29, 2023	Mar. 01, 2023	Feb. 01, 2023	May 17, 2022	Mar. 22, 2022	May 29, 2020	Jan. 10, 2023	Aug. 31, 2022	Mar. 22, 2022	Feb. 28, 2023	Dec. 06, 2022	Nov. 30, 2022	Sep. 30, 2023	Mar. 31, 2023	Feb. 28, 2023	Feb. 28, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Jun. 29, 2023	May 01, 2023	Jan. 03, 2023	Oct. 24, 2022	Sep. 01, 2022	Aug. 01, 2022
Debt Instrument [Line Items]
Proceeds from Issuance of Common Stock																				$ 3,494	$ 14,270
Gain on extinguishment of debt																				(2,196)	0
Exercise price of warrants						$ 60.75							$ 5.99375											$ 1.4375			$ 26.25
Change in fair value of warrants and derivatives															$ (3,587)				$ 0	$ (717)	(7)
principal amount																										$ 500
Warrant to purchase of common stock						2,469
Common stock, par value						$ 0.01									$ 0.01					$ 0.01		$ 0.01
Gain (Loss) on Extinguishment of Debt, Total																				$ (2,196)	0
Common Stock, Shares, Issued															12,164,753					12,164,753		1,623,913
Preferred Stock, Shares Issued															36,267					36,267		0
Common Stock
Debt Instrument [Line Items]
Common Stock, Shares, Issued																							6,961,867
MAM Eagle Lender, LLC
Debt Instrument [Line Items]
principal amount																									$ 500
Credit Agreement
Debt Instrument [Line Items]
Gain on extinguishment of debt																$ 2,196
Line of credit facility, maximum principal amount								$ 50,000							$ 0					$ 0
Line of credit facility, drawn on or before date								May 29, 2025
Term loan, interest rate								13.50%
Term loan, frequency of payments								month
Term loan, extended expiration date								May 29, 2026
EBITDA								$ 10,000
Amortization period								36 months
Term loan, exit fee due, principal amount advanced by lenders								$ 700
Term loan, exit fees								700
Exit fee percentage															2.50%					2.50%
Current outstanding loan balance															$ 250					$ 250
Financial covenants, minimum liquidity requirement								5,000
Debt issuance costs								1,496
Change in fair value of warrants and derivatives								$ 1,423
Debt issuance cost amortization															$ 263				$ 209	$ 263	$ 421
additional payment of principal		$ 500			$ 300																	$ 300
cash covenant	$ 4,000		$ 2,500											$ 3,000			$ 4,500
Gain (Loss) on Extinguishment of Debt, Total																$ 2,196
Credit Agreement \| Common Stock
Debt Instrument [Line Items]
Exercise price of warrants			$ 1.8951
Warrant to purchase of common stock			785,026
Common stock, par value			$ 0.01
Credit Agreement \| Lender
Debt Instrument [Line Items]
amendment fee																						200
Credit Agreement \| Agent
Debt Instrument [Line Items]
amendment fee																						$ 5
Credit Agreement \| MAM Eagle Lender, LLC
Debt Instrument [Line Items]
Financial covenants minimum liquidity requirement increased amount										$ 5,000
Percentage of cash used to repay outstanding under the credit agreement																												30.00%
Financial covenants, minimum liquidity requirement										$ 3,000
cash covenant				$ 3,000					$ 4,500			$ 2,225	$ 3,000					$ 4,500
Credit Agreement \| MAM Eagle Lender, LLC \| Common Stock
Debt Instrument [Line Items]
Exercise price of warrants								$ 6,426
Warrants expiration date								May 29, 2027
Credit Agreement \| After Third But Prior To Fourth Anniversary of Tranche One, Two, Three, Four or Five Loans
Debt Instrument [Line Items]
Term loan, prepayment of principal percentage								3.00%
Amended Credit Agreement
Debt Instrument [Line Items]
Exit fee percentage															19.30%					19.30%
Bond Payable
Debt Instrument [Line Items]
Accrued Interest																				$ 239
Debt instrument, maturity date											Nov. 30, 2022
Debt instrument, interest rate							5.00%				5.00%
Debt Instrument, Maturity Date											Nov. 30, 2022
Convertible Term Loan, percentage							5.00%				5.00%
Proceeds from convertible debt							$ 1,000
Debt interest rate description							accrued interest at a rate of 5% per annum during the period from April 8, 2022 to the maturity date of November 30, 2022
Debt interest penalty							20.00%
Bond Payable \| Series X Convertible Preferred Stock [Member]
Debt Instrument [Line Items]
Preferred Stock, Shares Issued							1,858				1,858
Bond Payable \| Convertible Common Stock [Member]
Debt Instrument [Line Items]
Common Stock, Shares, Issued							83,128				83,128
Employee Promissory Notes
Debt Instrument [Line Items]
Debt instrument, interest rate																						5.00%
Including of accrued expenses and other current liabilities															$ 241					$ 241
Maximum \| Credit Agreement
Debt Instrument [Line Items]
Term loan, exit fee due, percentage of principal amount advanced by lenders								2.50%
Maximum \| Credit Agreement \| On or Prior To Third Anniversary of Tranche One, Two, Three, Four or Five Loans
Debt Instrument [Line Items]
Term loan, prepayment of principal percentage								5.00%
Tranche One Loans \| Credit Agreement
Debt Instrument [Line Items]
Line of credit facility, maximum principal amount								$ 10,000
Term Loans \| Credit Agreement
Debt Instrument [Line Items]
Line of credit facility, maximum principal amount								$ 40,000